Abiodun Joseph Fatoba

Dr. Abiodun Joseph Fatoba

University of KwaZulu Natal, Durban, KwaZulu-Natal, South Africa
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2018 in Journal of Parasitic Diseases
Verified
Journal Article
Closed access
PDF file
AFAbiodun Joseph Fatoba
Abiodun Joseph Fatoba
MAMatthew Adekunle Adeleke
Matthew Adekunle Adeleke

1 January 2019 in Acta Virologica
Verified
Journal Article
Closed access
AFAbiodun Joseph Fatoba
Abiodun Joseph Fatoba
MAMatthew Adekunle Adeleke
Matthew Adekunle Adeleke
Chicken anemia virus: A deadly pathogen of poultry

21 July 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
AFAbiodun Joseph Fatoba
Abiodun Joseph Fatoba
MOMoses Okpeku
Moses Okpeku
MAMatthew Adekunle Adeleke
Matthew Adekunle Adeleke
Mycoplasma genitalium infection is a sexually transmitted infection that causes urethritis, cervicitis, and pelvic inflammatory disease (PID) in men and women. The global rise in antimicrobial resistance against recommended antibiotics for the treatment of M. genitalium infection has triggered the need to explore novel drug targets against this pathogen. The application of a bioinformatics approach through subtractive genomics has proven highly instrumental in predicting novel therapeutic targets against a pathogen. This study aimed to identify essential and non-homologous proteins with unique metabolic pathways in the pathogen that could serve as novel drug targets. Based on this, a manual comparison of the metabolic pathways of M. genitalium and the human host was done, generating nine pathogen-specific metabolic pathways. Additionally, the analysis of the whole proteome of M. genitalium using different bioinformatics databases generated 21 essential, non-homologous, and cytoplasmic proteins involved in nine pathogen-specific metabolic pathways. The further screening of these 21 cytoplasmic proteins in the DrugBank database generated 13 druggable proteins, which showed similarity with FDA-approved and experimental small-molecule drugs. A total of seven proteins that are involved in seven different pathogen-specific metabolic pathways were finally selected as novel putative drug targets after further analysis. Therefore, these proposed drug targets could aid in the design of potent drugs that may inhibit the functionality of these pathogen-specific metabolic pathways and, as such, lead to the eradication of this pathogen.

1 August 2021 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
LMLeah Maharaj
Leah Maharaj
VAVictoria Teniola Adeleke
Victoria Teniola Adeleke
AFAbiodun Joseph Fatoba
Abiodun Joseph Fatoba
AAAdebayo A. Adeniyi
Adebayo A. Adeniyi
STSelaelo I. Tshilwane
Selaelo I. Tshilwane
MOMoses Okpeku
Moses Okpeku

1 May 2020 in Acta Tropica
Verified
Journal Article
Closed access
AFAbiodun Joseph Fatoba
Abiodun Joseph Fatoba
MAMatthew Adekunle Adeleke
Matthew Adekunle Adeleke

14 September 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TMThabile Madlala
Thabile Madlala
VAVictoria Teniola Adeleke
Victoria Teniola Adeleke
AFAbiodun Joseph Fatoba
Abiodun Joseph Fatoba
MOMoses Okpeku
Moses Okpeku
AAAdebayo A. Adeniyi
Adebayo A. Adeniyi
MAMatthew Adekunle Adeleke
Matthew Adekunle Adeleke
Drug resistance against coccidiosis has posed a significant threat to chicken welfare and productivity worldwide, putting daunting pressure on the poultry industry to reduce the use of chemoprophylactic drugs and live vaccines in poultry to treat intestinal diseases. Chicken coccidiosis, caused by an apicomplexan parasite of Eimeria spp., is a significant challenge worldwide. Due to the experience of economic loss in production and prevention of the disease, development of cost-effective vaccines or drugs that can stimulate defence against multiple Eimeria species is imperative to control coccidiosis. This study explored Eimeria immune mapped protein-1 (IMP-1) to develop a multiepitope-based vaccine against coccidiosis by identifying antigenic T-cell and B-cell epitope candidates through immunoinformatic techniques. This resulted in the design of 7 CD8+, 21 CD4+ T-cell epitopes and 6 B-cell epitopes, connected using AAY, GPGPG and KK linkers to form a vaccine construct. A Cholera Toxin B (CTB) adjuvant was attached to the N-terminal of the multiepitope construct to improve the immunogenicity of the vaccine. The designed vaccine was assessed for immunogenicity (8.59968), allergenicity and physiochemical parameters, which revealed the construct molecular weight of 73.25 kDa, theoretical pI of 8.23 and instability index of 33.40. Molecular docking simulation of vaccine with TLR-5 with binding affinity of − 151.893 kcal/mol revealed good structural interaction and stability of protein structure of vaccine construct. The designed vaccine predicts the induction of immunity and boosted host's immune system through production of antibodies and cytokines, vital in hindering surface entry of parasites into host. This is a very important step in vaccine development though further experimental study is still required to validate these results.